Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

IQVIA Holdings, Inc. Common Stock (NY:IQV)

162.80 -2.73 (-1.65%)
Official Closing Price Updated: 7:00 PM EDT, Jul 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about IQVIA Holdings, Inc. Common Stock

< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
IQVIA & (RED) Announce Groundbreaking Partnership to Support Laboratory System Strengthening
From IQVIA
Via Business Wire
Global Oncology R&D Activity Remains High and More Patients Have Been Treated for Cancer, says IQVIA Institute for Human Data Science
From IQVIA
Via Business Wire
IQVIA Announces Pricing of Upsized Offering of Senior Secured Notes and Senior Notes
From IQVIA Holdings Inc.
Via Business Wire
IQVIA Hldgs's Return On Capital Employed Overview
Via Benzinga
Expert Ratings for IQVIA Hldgs
Via Benzinga
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,100 Today
Via Benzinga
IQVIA Announces Offering of Senior Secured Notes and Senior Notes
From IQVIA
Via Business Wire
IQVIA Celebrates Sheetal Telang, Winner of Healthcare Businesswoman's Association Rising Star Award
From IQVIA
Via Business Wire
Use of Medicines in the U.S. Continued to Grow in 2022 while Patient Out-of-Pocket Costs Remain Low, Says IQVIA Institute
From IQVIA
Via Business Wire
This Foreboding Sign Looms Over IQVIA Hldgs's Chart
Via Benzinga
Death Cross Looms Over IQVIA Hldgs Investors
Via Benzinga
The Latest Analyst Ratings for IQVIA Hldgs
Via Benzinga
$100 Invested In This Stock 5 Years Ago Would Be Worth $200 Today
Via Benzinga
Here's How Much You Would Have Made Owning IQVIA Hldgs Stock In The Last 5 Years
Via Benzinga
IQVIA Reports First-Quarter 2023 Results; Reaffirms Full-Year 2023 Guidance
From IQVIA Holdings Inc.
Via Business Wire
IQVIA Named a Leader in Everest Group Life Sciences Customer Experience Platforms PEAK Matrix® Assessment 2023
From IQVIA
Via Business Wire
IQVIA to Announce First-Quarter 2023 Results on April 27, 2023
From IQVIA Holdings Inc.
Via Business Wire
(IQV) - Analyzing IQVIA Hldgs's Short Interest
Via Benzinga
What 6 Analyst Ratings Have To Say About IQVIA Hldgs
Via Benzinga
Here's How Much $100 Invested In IQVIA Hldgs 5 Years Ago Would Be Worth Today
Via Benzinga
Where IQVIA Hldgs Stands With Analysts
Via Benzinga
IQVIA Clocks 2.8% Sales Growth In Q4, Beats Street View By A Whisker
Via Benzinga
2 Clinical Research Stocks That Could Grow by More Than 10% This Year, and 1 to Watch
These companies strive to bring down the cost of developing new therapies. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For March 17, 2023
Via Benzinga
Global Clinical Trial Activity Remained Resilient in 2022 Despite The Continued Pandemic, Says IQVIA Institute
From IQVIA
Via Business Wire
IQVIA CFO Ron Bruehlman to Speak at Barclays Global Healthcare Conference on March 15, 2023
From IQVIA
Via Business Wire
MannKind To Rally Around 30%? Here Are 10 Other Analyst Forecasts For Monday
Piper Sandler cut the price target for CS Disco, Inc. (NYSE: LAW) from $11 to $7.5. Piper Sandler analyst Arvind Ramnani downgraded the stock from Overweight to Neutral. CS Disco shares fell 1.2% to... 
Via Benzinga
IQVIA Publishes its 2022 Environmental, Social and Governance Report
From IQVIA
Via Business Wire
Got $300? 3 Growth Stocks to Buy That Could Double Your Money
All three companies have shown consistent revenue and EPS growth. 
Via The Motley Fool
7 Hot Healthcare Stocks With the Potential to Outperform
These healthcare stocks to buy now have the potential to outperform the market over the long-term because their businesses are strong. 
Via InvestorPlace
< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.